Covid vaccine candidate by Hyd co set for trials

India’s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV), has received Drug Controller General of India (DCGI) approval for phase I and II human trials.

from Hyderabad News & Coronavirus Live Updates: Latest Hyderabad News Headlines & Coronavirus News Updates from Hyderabad - Times of India https://ift.tt/2VsUE44